HBcrAg is a predictor of post-treatment recurrence of hepatocellular carcinoma during antiviral therapy (Q42907651)

From Wikidata
Jump to navigation Jump to search
scientific article published on 14 September 2010
edit
Language Label Description Also known as
English
HBcrAg is a predictor of post-treatment recurrence of hepatocellular carcinoma during antiviral therapy
scientific article published on 14 September 2010

    Statements

    HBcrAg is a predictor of post-treatment recurrence of hepatocellular carcinoma during antiviral therapy (English)
    Miharu Hirakawa
    Hiromi Yatsuji
    14 September 2010
    1461-1470

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit